Cargando…

Biosimilars Have Arrived: Rituximab

A biosimilar is a biologic product that is highly similar to a licensed biologic (“originator”) such that there are no clinically meaningful differences in safety, purity, or potency between the biosimilar and the originator. As patent protection and data exclusivity for the biologic rituximab expir...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenwald, Maria, Tesser, John, Sewell, K. Lea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885398/
https://www.ncbi.nlm.nih.gov/pubmed/29765782
http://dx.doi.org/10.1155/2018/3762864